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Various clinical and pathological conditions can develop after EBV infections de-
pending on the age ofthe individual. Whereas youngchildren show a silent serocon-
version, adolescents with acuteEBV infection develop infectious mononucleosis (IM)
in half of the cases. Being a lymphotropic virus, EBV can trigger an unspecific B
cell stimulation besides the specific immune response. This may cause a big rise
of class G and M Igs in the sera. Little is known about their specificity. Heterophil
antibodies appear that agglutinate sheep, horse, and bovine erythrocytes (1, 2). Cold
antibody with anti-i specificity was found in 8% to 60-70% of the IM patients (3,
4). In addition, antibodies are found that react with components of the cytoskeleton
(5) or possess antinuclear features (6). None of these antibodies always appears in
acute EBV infection, thus, their significance for the pathogenesis of IM is not clear.
This may be different in the antibodies we recently detected in all sera of persons
acutely infected with EBV These antibodies possess specificity for the glycolytic en-
zyme, triosephosphate isomerase (TPI).
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Materials and Methods
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Preparing the Antigens.
￿
Frozen cells (1 ml packed volume) and disrupted tissues were al-
lowedto thaw, and were subsequently resuspended in equal volumes of modified lysis buffer
(7) containing 9.5 M urea, 2% (wt/vol) NP-40, and 5% 6-ME; further extraction was done
by five cycles of freezing and thawing (-20°C/room temperature). The cell lysate was then
centrifuged at 3,000 g for 15 min. The supernatant fluid was used for antigen preparation
by SDS-PAGE followed by immunoblotting. The protein concentration (20 mg/ml) was mea-
sured by the method of Neuhoff et al. (8).
PAGE.
￿
Composition and electrophoresis of SDS-13% (wt/vol) polyacrylamide slab gels
were performed as reported by Laemmli (9). The electrotransfer of proteins from SDS gels
to hydrophobe polyvinylilenedifluoride (PVDF) membrane (Millipore Continental Water
Systems, Bedford, MA) was performed by transversal electrophoresis (10).
Immunostaining the Blots.
￿
For the detection of antibodies, sera, as well as secondary anti-
bodies conjugated with peroxidase, were diluted in 20% FCSTBS (vol/vol). Each antibody
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was incubated while continuously shaken for 1 h at room temperature . The sera were diluted
1 :50, as the second antibody, a peroxidase conjugated anti-human IgM, was used in a dilu-
tion of 1 :1,000.
Isolation and Purification ofp26/p29.
￿
P26 and p29 were isolated from Raji cell lysate by
means ofelectroelution (11) after preparative SDS-13% PAGE . After further purification on
an SDS-10-18% gradient polyacrylamide gel, the electrotransfer on PVDF for the protein
sequencing was performed .
Cyanogen Bromide Cleavage.
￿
Purified p29 was cleaved by cyanogen bromide according to
the method of Schroeder et al . (12). The fragments were separated in SDS-18% PAGE .
Determination ofAmino Acid Sequence.
￿
For the determination of amino acid sequence, an
automatic gas phase sequencer(470A ; Applied Biosystems ; Inc ., Foster City, CA) was used (13) .
TPIfrom otherSpecies.
￿
Commercially available TPI from dog, pig, and rabbit (muscle tissue),
as well as from yeast (Sigma Chemical Co., FRG) were used for comparison . For gel elec-
trophoresis, protein concentrations were adjusted to 1 mg/ml .
Affinity Purification ofAntiTPIAntibodies.
￿
Electrophoretic transfer ofp29 (human TPI) from
gels toPVDF membrane was carried out as described elsewhere (10) . After transfer, thePVDF
membrane was treated with sera from IM patients . The elution of antibodies was performed
using the method described by Olmsted (14) .
"Cr Release Assay.
￿
500 A1 of a 10% suspension ofhuman erythrocytes group 0 Rhesus
negative was marked with 5 /Xi 5'Cr for 1 h at room temperature. 10 Al of "Cr-marked
erythrocytes was incubated with 10,1 ofinactivated proband's serum for 2 h at 37°C . After-
wards, 10 Al of guinea pig serum was added as a source for complement . Guinea pig serum
had previously been absorbed on human erythrocytes blood group O, Rhesus negative for
4 h at room temperature . Each assay was done in quadruplicate . Percentage of"Cr release
was calculated as : 100x (cpm in supernatant/cpm total) .
Results and Discussion
When investigating the IgM fractions ofIM sera, it was striking that all IM sera
cause a cytoplasmic fluorescence not only in EBV genome-positive cells, but also
in negative cells . This reaction was missing with EBV seronegative sera . For iden-
tification of the antigens (see Fig . 1), EBV genome-positive and -negative cells
FIGURE 1 .
￿
Detection of p26/p29 in cell lysates . (Lane 1)
Protein marker coomassie blue stained; (lane 2) Raji ly-
sate; (lane 3) MOLT 4 cell lysate; (lane 4) human erythro-
cyte group0 lysate . The reaction ofthe cell lysates was per-
formedwith serum derivingfroma patient intheacute stage
ofIM (A) and with serum from a healthy volunteer (B).RITTER ET AL .
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were lysed, and the lysate was separated in the SDS-PAGE . After electrotransfer
on aPVDF membrane, they were used for the immune reaction with IM sera. All
IM sera reacted with two cellular structural components that were identified as pro-
teins of a molecular mass of 26,000 (p26) and 29,000 daltons (p29), respectively .
Both proteins arepresent in allmammalian cells investigated: human lymphoblastoid
cell lines, primary human lymphocytes, and human erythrocytes . They were also
found in mouse cells, as well as in rabbit and duck erythrocytes .
The antibodies against p26 and p29 found in all 182IM sera tested all belonged
to the Ig classM (IgM) . They were not detected before EBV infection. IgM anti-
p26 and IgM anti-p29 appear in high levels in sera of IM patients at the time of
the outbreak of clinical symptoms . Their rise and fall is very similar to that of the
IgM antibodies against the EBV capsid antigen. 5-6 mo later, anti-p26/anti-p29
are no longer detectable . A switch to IgG does not occur.
Both regularity and intensity of the immunological reaction were reasons for fur-
ther work and identification of the cellular antigens p26 and p29 . The two proteins
were isolated from Raji cell lysates . After purification the sequence of the 11 NH2-
terminal amino acidsofp29 was performed with a gasphase sequencer. The sequence
gained was compared with the data of the Dayhoffchart . Apart from an exchange
at position 5Pro vs . 5Lyg, the sequence of the amino acids coincided with that of
humanTPI . In addition, the sequences of the fragments gained by cyanogen bro-
mide cleavage were in concordance with TPI (see Fig. 2) . TPI consists of two iden-
tical parts with a molecular mass of 26,500 each . P26 is blocked NH2 terminally.
It will be analyzed soon .
To find out whetherIgM anti-p29 really recognizes TPI, commercially available
TPI preparations were treated with IM sera (see Fig. 3) . Whereas IgM anti-p29
recognized human, rabbit, and dog TPI, there was no reaction with TPI derived
from pig and yeast. These data correspond with the sequence data stating an ho-
FIGURE 2 . Identification of p29 . (A)
Lane 1, p29 after CNBr-cleavage (coom-
assie blue) ; lane 2, purified p29 (coomassie
blue); lane 3, p29 after CNBr-cleavage
(immunoblot). (B) a, Amino acid sequence
ofhumanTPI (15) ; b, p29, 11 amino acids
from NH2terminus, 10 amino acids from
the CNBr-fragment 2, 14 amino acids
from the CNBr-fragment3 . The arrows
point to the location ofCNBr cleavage; un-
derliningshows exchange ofamino acids;
one letter code was used .568
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FIGURE 3 .
￿
Demonstration ofthe serological
identity of p29 andTPI . (A) Silver staining;
(B)immunoblot ; lane 1, TPI rabbit; lane 2,
TPI pig, lane 3, TPI yeast; lane 4,TPIdog;
lane 5a, lysate from Raji cells ; lane 56, mo-
lecular marker.
mology of>90% between man and rabbit (15), but only of40% between man and
yeast (16) . Theaminoacid sequences ofTPIfrom dogsandpigs arenotknown(Iayhoff
protein data base) . Further, it was demonstrated that rabbit TPI absorbed anti-p29
antibodies from IM sera (data not shown) . Thus, p29 is one of the two subunits
ofTPI . TheIgM anti-p29 antibodies produced in thecourse of acuteEBVinfection
are directed against TPI .
TPI is a glycolysis enzyme . Cells that take their energy mainly from glycolysis
are particularly susceptible to disturbances of theenzyme function leading to mem-
brane instabilities, spherocytosis, and in most serious cases, to hemolytis (17) . The
full picture of hemolytic anemia is a rare complication of IM, but often mild and
multifactorial anemia is found in the disease . Several reports have linked the anti-i
antibody with hemolytic phenomena in IM (18, 19) . The sera taken from IM pa-
tients suffering from hemolytic anemia, however, proved to be negative for anti-i
antibodies (20) . It seems likely that additional mechanisms are effective in the cases
of hemolytic anemia accompanying IM .
Antibodies against TPI taken from IM sera purified in their affinity bind to O,
Rh- RBC, and induce a"Cr release in the presence ofcomplement. An antibody
against p29 induced in rabbits is distinctively effective (see Fig . 4) .
FIGURE 4.
￿
"Cr release from
human erythrocytes group O,
Rhesus negative. Reaction of
serum negative for IgM anti-
p29 (hatched bass); reaction of
serum positive forIgM anti-p29
(solid bars) .RITTER ET AL.
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We assume that the antiTPI antibody is responsible for disturbances of erythro-
cytes in patients with IM; however, as yet, we have no firm evidence concerning
the mechanism. The 5'Cr release in vitro is not accompanied by massive lysis of
the RBC. Also, we would not expect this according to the in vivo situation, as all
patients with IM produce anti TPI, but only 3 % develop hemolysis. It is conceiv-
able that the effect of antiTPI is a two-step mechanism: first, an initial reaction on
the membrane requiring complement, which is then followed by an influx of anti-
TPI into the cell where it acts. The extent of the initial damage of the membrane
would influence the further incidence of hemolysis. The reaction on the membrane
may be understood as a molecular mimicry between TPI and a component of the
outer section ofthe erythrocyte membrane. Further information concerningthe epitope
of TPI that is recognized by antiTIM of IM patients will be of interest.
Summary
In sera from patients with acute EBV, infection and the clinical symptoms of in-
fectious mononucleosis antibodies of the Ig class M were found that are directed
against two cellular proteins. The molecular mass of these proteins was determined
to be 29 (p29) and 26 kD (p26), respectively, in SDS-PAGE. P29 was identified as
part of the glycolytic enzyme triosephosphate isomerase (TPI) by comparison of the
NH2-terminal amino acid sequences. A purified antibody against TPI induces a
"Cr release from human erythrocytes. Possibly, antiTPI causes hemolysis, which
is an infrequent but serious symptom of infectious mononucleosis.
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